Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novo Nordisk prepares new glucagon receptor agonists

Oct. 18, 2011

Scientists at Roche present novel farnesoid X receptor agonists

Oct. 18, 2011

Controlled-release phentermine/topiramate formulation shows long-term benefit in obesity

Oct. 18, 2011

Migalastat hydrochloride evaluated in female patients with Fabry's disease

Oct. 17, 2011

Azelon raises funds to support development of nasal spray for osteoporosis

Oct. 17, 2011

Merck & Co. terminates JTT-305 licensing agreement

Oct. 17, 2011

Depomed releases topline data from BREEZE 3 trial of Serada in menopausal hot flashes

Oct. 17, 2011

Isis Pharmaceuticals selects second development candidate in GlaxoSmithKline collaboration

Oct. 14, 2011

BioSante Pharmaceuticals reports phase III safety data on LibiGel

Oct. 13, 2011

Dosing complete in phase I trial of Antisense Therapeutics drug

Oct. 13, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.